Acrolein is a highly reactive a,b-unsaturated aldehyde produced endogenously during lipid peroxidation and naturally distributed pervasively in living environments, posing serious threats to human health if not properly metabolized. In this study, we report aldose reductase-like-1 (ARL-1) as a novel enzyme that catalyzes the reduction of acrolein and protects cells from their toxicity. Using purified ARL-1 protein, we determined its enzymatic activity in response to acrolein and defined its steady-state kinetics with K m and V max at 0.110 ± 0.012mM and 3122.0 ± 64.7 nmol/mg protein/min, respectively. By introducing a functional Enhanced Green Fluorescent Protein (EGFP)/ARL-1 fusion protein into 293T cells, we demonstrated that plating efficiency in liquid culture and focus formation in soft agar increased by more than 60% (p < 0.05), compared to the vector control cells. More significantly, at a low dose of 5mM acrolein, EGFP/ARL-1 expression enhanced both plating efficiency and focus formation by more than threefold, and the foci (in soft agar) of 293T cells expressing EGFP/ ARL-1 were significantly larger than those of the vector control cells. At high concentrations of acrolein (25 and 50mM), EGFP/ARL-1 protein prevented oncotic death of 293T cells induced by acrolein. In summary, our data demonstrated for the first time that the ARL-1 protein protects 293T cells from acrolein toxicity. Due to the high toxicity and wide distribution of acrolein, this finding is important to the understanding of its detoxification mechanisms.
Acrolein (CH 2 ¼CH-CHO, 2-propenal) is a highly reactive a,b-unsaturated aldehyde produced by photochemical reaction and incomplete combustion or pyrolysis of organic materials, such as wood, leaves, fuel, and tobacco (Kehrer and Biswal, 2000) . As an air pollutant, acrolein represents up to 13% of total atmospheric aldehydes and 8% of aldehydes generated from vehicles and residential fireplaces (Ayer and Yeager, 1982; Li et al., 2004) . Further, acrolein is also a component of heated cooking oil and foodstuffs (Beauchamp et al., 1985; Kehrer and Biswal, 2000) . In addition to dietary and environmental resources, acrolein is also constantly produced intracellularly during lipid peroxidation (Uchida et al., 1998) , antitumor drug (e.g., cyclophosphamide) metabolism (Fraiser et al., 1991) , and oxidation of threonine catalyzed by neutrophil myeloperoxidase (Anderson et al., 1997) . Therefore, acrolein is a widely present, hazardous carbonyl to which humans are exposed on a daily basis.
Among all unsaturated aldehydes, acrolein is the strongest electrophile, showing high reactivity with cellular nucleophiles in amino acids, peptides, proteins, and DNA, forming covalently modified adducts (Kehrer and Biswal, 2000; Sierra et al., 1991; Steinbrecher et al., 1987; Uchida et al., 1998) . Therefore, acrolein can inhibit cell proliferation (Horton et al., 1997; Kehrer and Biswal, 2000) , cause DNA damage (Sierra et al., 1991) , suppress neutrophil apoptosis (Finkelstein et al., 2001 ), or induce cell death (Rudra and Krokan, 1999) depending upon the exposure concentration. Acute inhalation of acrolein can result in severe respiratory irritation, distress, and cell necrosis; and by ingestion, acrolein can cause acute gastrointestinal lesions (Ghilarducci and Tjeerdema, 1995) . Acrolein is also mutagenic and carcinogenic. By interacting with DNA, acrolein causes mutations in bacteria and cultured cells and induces urinary bladder carcinogenesis in experimental rats (Li et al., 2004) . Therefore, acrolein possesses substantial threats to humans.
In view of the pervasive distribution, strong reactivity, and subsequent risks to human health, a need is warranted for a comprehensive understanding of cellular defensive systems against acrolein and the consequences of defects in such defensive systems. Unfortunately, this remains to be clarified. Aldehyde dehydrogenases (ALDHs) were reported to catalyze the oxidation of acrolein to carbonic acid, but cellular protection was not documented when overexpressed in V79 cells, a hamster fibroblast cell line (Townsend et al., 2001) . Glutathione-S-transferases A5 (GSTA5) and aldo-keto reductase family 7 A1 (AKR7A1) showed their protection of V79 cells from acrolein toxicity by catalyzing the conjugation of acrolein to glutathione or its reduction to less toxic alcohol form. However, related enzyme catalytic data were not available (Ellis and Hayes, 1995; Gardner et al., 2004; Kazi and Ellis, 2002) . Aldose reductase-like-1 (ARL-1, also designated aldo-keto reductase family 1 B10, AKR1B10) is a protein isolated from human hepatocellular carcinoma (HCC) (Cao et al., 1998) . In normal tissues, this protein is primarily expressed in the small intestine and colon, with lower levels in the liver, thymus, prostate, and testis. Interestingly, this gene was overexpressed in approximately 54% of the HCC tissues, 84.4% of lung squamous cell carcinomas, and 29.2% of lung adenocarcinomas in smokers (Cao et al., 1998; Fukumoto et al., 2005; Penning, 2005) . This study demonstrates for the first time ARL-1 as a critical protein protecting cultured cells from acrolein toxicity.
MATERIALS AND METHODS
Cell culture. Transformed human kidney cell line, 293T (American Type Culture Collection, Manassas, VA), was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heated fetal bovine serum (FBS), 2mM glutamine, 100 U/ml penicillin, and 100 lg/ml streptomycin at 37°C, 5% CO 2 . Cells at 85-90% confluence were passaged by trypsinization.
Purification and enzymatic activity of ARL-1 recombinant protein. ARL-1 recombinant protein was prepared as described previously (Cao et al., 1998) . Acrolein substrate activity was determined in a mixture consisting of 135mM sodium phosphate (pH 7.0), 0.2mM reduced nicotinamide adenine dinucleotide phosphate (NADPH), 1.0mM b-mercaptoethanol, 50mM KCl, 2 lg ARL-1 protein, and acrolein ranging from 10lM to 20mM. Reaction mixtures without acrolein and ARL-1 protein were used as controls. The mixtures were incubated at 35°C for 20 min. Oxidized NADPH was measured at OD 340 to indicate ARL-1 activity. Michaelis-Menten constants (K m and V max ) were calculated with GraphPad Prism 4 (Graph Pad Software, San Diego, CA). To measure ARL-1 activity in 293T cells, the cells were lysed on ice in a buffer containing 20mM NaH 2 PO 4 , 2mM dithiothreitol (DTT), 5lM leupeptin, and 20lM phenylmethylsulfonyl fluoride (PMSF) for 30 min, followed by centrifugation at 10,000 3 g, 4°C for 10 min. Soluble proteins (50 lg) were used for ARL-1 activity assay, using 20mM DL-glyceraldehyde as a substrate (Cao et al., 1998) .
Construction of EGFP/ARL-1 expression vector and transient transfection. A eukaryotic expression vector of EGFP/ARL-1 fusion protein was constructed by inserting ARL-1 cDNA into EGFP-C3 (Promega, Madison, WI) at PstI and ApaI sites. Sequences at conjunction sites were verified by DNA sequencing analysis. Cells (293T) were plated at 2 3 10 5 cells per well in sixwell plates for 24 h. Plasmid DNA (1.6 lg) and Lipofectamine (3 ll) were mixed in 200 ll Opti-Minimum Essential Medium (MEM) I medium, incubated at room temperature for 20 min, and then applied to cells in 1 ml of Opti-MEM I medium for 4 h, followed by the addition of 1 ml of fresh medium with 20% of FBS. Cells continued to incubate until harvest as indicated.
Western blot analysis. Western blot was performed as previously described (Cao et al., 2002) . Briefly stated, 293T cells were lysed on ice for 30 min with lysis buffer (10mM N-2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid, 10mM KCl, 1mM ethylenediaminetetraacetic acid [EDTA] [pH 8.0], 0.1% NP-40, 1mM DTT, 1mM PMSF, and 0.5mM Na 3 VO 4 ). Soluble protein (30 lg) was separated on a 12% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis gel and blotted onto a pure nitrocellulose membrane (Bio-Rad, Hercules, CA) at 180 mA for 2 h. After blockage with 5% skim milk in phosphate-buffered saline at room temperature for 45 min, membranes were incubated with ARL-1 antibody (1:500, generated in our laboratory) in the same buffer for 1 h, followed by incubation with goat anti-rabbit IgG (1:2000) for 1 h. Antibody binding was detected using enhanced chemiluminescence system (Pierce, Rockford, IL). To correct protein loading amounts, the membranes were reprobed with b-actin monoclonal antibody (1:40,000) (Sigma, St. Louis, MO).
Acrolein cytotoxicity, lactate dehydrogenase leakage, and DNA fragmentation assays. To determine the effect of EGFP/ARL-1 protein expression on cell susceptibility to acrolein, transfected 293T cells were plated in 12-well plates at 5 3 10 4 cells per well. After 24 h, cells were fed with fresh medium containing acrolein at 25 or 50lM for 72 h. Viable cells were trypsinized and counted by trypan blue staining using a Coulter Counter (Beckman Coulter, Fullerton, CA).
Acute cell death was estimated by lactate dehydrogenase (LDH) efflux. Cells were plated at 5 3 10 4 cells per well in 12-well plates and exposed to 50lM of acrolein for 12 h. Medium was collected and cells were lysed for 10 min in 0.5% (vol/vol) Triton X-100 in 0.1M potassium phosphate buffer (pH 7.4). Supernatants were collected by centrifugation at 10,000 3 g for 5 min. LDH activity in medium and cell lysates was measured using LDH assay kit (Roche, Indianapolis, IN). Samples (100 ll each, diluted if necessary) were mixed with equal volumes of LDH reagent in 96-well plates. Three wells were prepared for each sample to obtain averages. After incubation at room temperature in the dark for 10 min, reactions were stopped by addition of 50 ll of 1 N HCl. Absorbance at 490 nm was read in a microplate reader (BioRad), with 650 nm as a reference wavelength. LDH release was calculated as: LDH release (%) ¼ LDH in medium/(LDH in medium þ LDH in cell lysate) 3 100 (Koh and Choi, 1987) .
DNA fragmentation was conducted to elucidate the mechanisms of cell death induced by acrolein. Cells (293T) were plated at 1.0 3 10 6 cells per 60-mm cell culture dish and cultured overnight. After being exposed to 50lM of acrolein for 12 h, the cells were harvested and lysed in 0.5% Triton X-100, 5mM Tris-HCl (pH 7.4), and 5mM EDTA for 20 min on ice, followed by centrifugation at 10,000 3 g for 15 min. Supernatants were incubated with 100 lg/ml of proteinase K (Applied Biosystems, Foster City, CA) in 0.5% SDS for 2 h at 56°C. DNA was extracted with phenol-chloroform and precipitated with ethanol. DNA pellets were dissolved in 20mM Tris-HCl (pH 7.4) with 50 lg/ml of RNase A and incubated at 37°C for 1 h. DNA products were then separated on 2% agarose gel.
Clonogenic assay. Clonogenic growth of 293T cells was evaluated by plating efficiency and anchorage-independent growth in soft agar. For plating efficiency tests, 293T cells were suspended, diluted at 100 cells/ml, and seeded at 150 cells per 60-mm culture dish, three dishes each. Cells were incubated in regular medium overnight and then fed with fresh medium containing acrolein (5lM). Cells were incubated for 14 days, and colonies were visualized by fixing in 10% formalin and staining with 0.01% crystal violet, each for 10 min. After being rinsed with water and allowed to air dry, colonies were photographed and scored. Plate efficiency (%) was calculated as: (colony number/seeded cell number) 3 100. The experiment was repeated three times. Anchorageindependent growth was tested by laying 150 cells in 0.5 ml of 0.3% agar in DMEM containing 10% FBS over 0.5 ml of 0.5% agar in same medium, three wells each. After incubating for 24 h, 200 ll of complete medium containing 5lM of acrolein was loaded on top of the agar, and cells were continuously incubated for 3 weeks. Formed foci were photographed and focus formation efficiency was scored as (%): (number of foci/number of seeded cells) 3 100. The experiment was repeated three times.
Statistic analysis. Statistic analysis was performed using Student's t-test with INSTAT statistical analysis package (Graph Pad Software). Significance was defined as p < 0.05.
RESULTS

Enzymatic Activity of ARL-1 Recombinant Protein Toward Acrolein
To determine the enzymatic activity of ARL-1 in relation to acrolein, its recombinant protein was expressed and purified ALDOSE REDUCTASE-LIKE-1 DETOXIFIES ACROLEIN using a prokaryotic protein expression system (Qiagen, Valencia, CA). As indicated in Figure 1A , a single protein band (approximately 36 kDa) was detected by Coomassie blue staining, indicating the purity of the prepared ARL-1 protein.
Enzymatic activity assay indicated that the recombinant ARL-1 protein has high affinity and enzymatic activity toward acrolein, with K m at 0.110 ± 0.012mM and V max at 3122.0 ± 64.7 nmol/mg protein/min (Fig. 1B) .
Expression and Function of EGFP/ARL-1 Fusion Protein in 293T Cells
By transient transfection, EGFP/ARL-1 fusion protein expression vector was delivered into 293T cells, estimating transfection efficiency at approximately 85% ( Fig. 2A) . To quantitate protein levels and enzymatic activity of this fusion protein, Western blot and enzymatic activity assays were performed. As shown in Figure 2B , this fusion protein with molecular weight of approximately 66 kDa (ARL-1 plus EGFP) was expressed at high levels in 293T cells transfected with EGFP/ARL-1 expression vector but undetectable in cells transfected with EGFP-C3 control vector. No endogenous ARL-1 protein was detected in these cells. Enzymatic activity assay indicated that this EGFP/ARL-1 fusion protein can efficiently catalyze reduction of DL-glyceraldehyde, using NADPH as a coenzyme (Cao et al., 1998) . The enzymatic activity in 293T cells transfected with EGFP/ARL-1 expression vector was fivefold higher than in the vector control cells (Fig. 2C ). These data indicated that 293T cells successfully expressed a functional EGFP/ARL-1 fusion protein.
Enhanced Clonogenic Growth of 293T Cells by Expression of EGFP/ARL-1 Protein
To understand the effect of ARL-1 activity on cell viability and clonogenic growth, plating efficiency and anchorageindependent growth of 293T cells were evaluated. As indicated in Figure 3 , introduction of EGFP/ARL-1 fusion protein into 293T cells significantly increased their plating efficiency in liquid culture by more than 60% (p < 0.05), compared to the vector control. When the plated cells were exposed to 5lM of acrolein, the plating efficiency of 293T cells with EGFP/ARL-1 expression was three times higher than in vector control cells. These data indicate that ARL-1 regulates both intracellular acrolein stress and cellular response to additional acrolein stress. In this study, differences in colony size were not observed (Fig. 3A) .
Anchorage-independent growth of 293T cells was further evaluated in soft agar. As shown in Figure 4 , delivery of EGFP/ ARL-1 fusion protein into 293T cells enhanced not only focus formation efficiency but also the size of foci. In regular culture conditions, focus formation of 293T cells with EGFP/ARL-1 expression increased by more than 60% (p < 0.05), and this rate was enhanced by more than threefold when exposed to 5lM of acrolein. Furthermore, the foci of 293T cells with EGFP/ARL-1 expression were significantly larger than those of vector control cells (Fig. 4A) , indicating that ARL-1 protected both focus formation and proliferation of 293T cells in semisolid culture.
Prevention of Acrolein-Induced Oncosis of 293T Cells by EGFP/ARL-1 Protein
EGFP/ARL-1 protein protected clonogenic growth of 293T cells at low doses of acrolein. To further understand whether this fusion protein protects 293T cells from acrolein toxicity at high doses, we examined the viability of 293T cells with EGFP/ARL-1 expression in response to acrolein at 25 and 50lM. As shown in Figure 5A , EGFP/ARL-1 fusion protein significantly prevented 293T cell death induced by acrolein at 25 (p < 0.05) and 50lM (p < 0.01), compared to the vector control cells. To understand the mechanisms of how acrolein induced 293T cell death, LDH efflux was measured to examine membrane integrity of dead cells. The resulting data demonstrated that at 50lM of acrolein, high LDH leakage was detected in vector control 293T cells, indicating that 293T cell death occurred with the loss of membrane integrity. The LDH efflux of EGFP/ARL-1 cells was more than twofold lower than that of vector control cells (Fig. 5B) , indicating that ARL-1 prevented 293T cell death induced by acrolein.
Having the EGFP protein tagged to ARL-1 limited annexin V-FITC staining and FACScan analysis. Therefore, DNA fragmentation within 293T dead cells was evaluated in the presence of 50lM of acrolein. Results indicated that the amount of DNA fragments in vector control cells was significantly more than in EGFP/ARL-1 cells, indicating that ARL-1 prevented 293T cells' DNA fragmentation induced by acrolein. Of the three types of cell deaths identified thus far (apoptosis, oncosis, and necrosis), oncosis is the only mechanism in which dead cells are characterized with membrane disintegration and annexin V staining or DNA fragmentation (Van Cruchten and Van Den Broeck, 2002) . Therefore, in this study, 293T cells experienced oncotic cell death when exposed to acrolein, and EGFP/ARL-1 protein prevented 293T cell death via this mechanisms.
DISCUSSION
This study demonstrated for the first time that ARL-1 is a novel enzyme that efficiently detoxifies acrolein, a highly electrophilic a,b-unsaturated aldehyde. The purified ARL-1 recombinant protein displayed strong enzymatic activity toward acrolein with K m and V max at 0.110 ± 0.012mM and 3122.0 ± 64.7 nmol/mg protein/min, respectively. Delivery of functional EGFP/ARL-1 fusion protein into 293T cells, a transformed human kidney cell line with high transfection efficiency, significantly protected cells from both endogenous (produced during cell metabolism) and additional (added into culture medium) acrolein stress. These were reflected on enhanced plating efficiency in liquid culture and focus formation rate and clonogenic growth in soft agar, both with and without the presence of acrolein (5lM). EGFP/ARL-1 protein also prevented 293T cell death induced by acute exposure of acrolein at 25 and 50lM, as indicated by reduced LDH leakage and DNA fragmentation.
Acrolein is an a,b-unsaturated carbonyl with high reactivity toward nucleophiles. This compound can form alkylated adducts through interaction with nucleophiles at C-3 double bond (Michael addition), C-1 carbonyl group (Schiff's base formation), or both C-3 and C-1 with 1,4 addition (Esterbauer et al., 1991; Uchida, 2000) . Therefore, acrolein can interact Values are means ± SD from three independent observations. *p < 0.05 or **p < 0.01.
FIG. 2.
Expression and function of EGFP/ARL-1 fusion protein in 293T cells. ARL-1 protein was fused to the C-terminus of the EGFP protein and transiently transferred into 293T cells as described in ''Materials and Methods'' section. Transfection efficiency was evaluated by EGFP expression (A). EGFP/ ARL-1 expression levels and functionality were tested by Western blot (B) and enzymatic activity (oxidized NADPH at nmol/mg protein/h) assay (C). No endogenous ARL-1 protein band was detected. Numbers on the left in (B) indicate molecular weight (kDa). Values in (C) indicate mean ± SD from three independent repeats. *p < 0.01. ALDOSE REDUCTASE-LIKE-1 DETOXIFIES ACROLEIN 565 with cysteine, histidine, and lysine residues of proteins and with nucleophilic sites in DNA, resulting in protein dysfunction, proteosome inhibition, and DNA mutations and breaks (Kehrer and Biswal, 2000; Li et al., 2004) . Further, through the formation of alkylated conjugates with glutathione, acrolein can result in glutathione depletion (Krokan et al., 1985; Rudra and Krokan, 1999) . These reactions and resulting consequences constitute the basis of cytotoxicity and genotoxic events (mutagenesis and carcinogenesis) in cells exposed to acrolein. Indeed, at low doses, acrolein inhibits cell proliferation (Horton et al., 1999; Horton et al., 1997) and may enhance apoptosis as a secondary toxin, while oncosis predominates at high concentrations (Kehrer and Biswal, 2000) . Therefore, considering the continuous production of acrolein in cellular metabolism and its wide distribution in living environments and foodstuffs, acrolein is a prevalent toxicant to humans.
Mammalian cells have developed a few lines of defense systems to block cells from acrolein toxicity, through which acrolein is reduced to a less toxic alcohol form, oxidized to carbonic acid, or conjugated with glutathione. ALDHs mediate the oxidative pathway, forming carbonic acids (Townsend et al., 2001) ; GSTA5 conjugates acrolein to glutathione (Kazi and Ellis, 2002) ; and AKR7A1 converts acrolein into its alcohol (Ellis and Hayes, 1995; Gardner et al., 2004) . In addition, leukotriene B4 12-hydroxydehydrogenase may detoxify acrolein by reducing the a,b-carbon-carbon double bond (Dick et al., 2001) . Nevertheless, the relative importance of these enzymes in detoxifying acrolein and protecting cells remains to be assessed. Some enzymes, such as ALDH1A1 and ALDH3A1, displayed enzymatic activity in vitro but failed to protect cells from acrolein toxicity (Townsend et al., 2001) .
Other enzymes such as GSTA5 demonstrated the cellular protection against acrolein, but detailed catalytic data were not available (Kazi and Ellis, 2002) . Catalytic efficiency of an enzyme is often a determinant of the detoxification capacity. In this study, we identified for the first time ARL-1 as a novel enzyme with strong enzymatic activity toward acrolein and efficient cellular protection against this compound.
ARL-1 recombinant protein exhibited strong enzymatic activity toward acrolein, which constitutes its protection of 293T cells against this compound. For the convenience of monitoring transfection efficiency and expression levels, an EGFP protein was tagged to N-terminus of ARL-1 protein, generating a fusion protein EGFP/ARL-1. The functionality of this fusion protein was verified by enzyme activity assay using DLglyceraldehyde as a substrate (Fig. 2) . To avoid compensatory protection of cells by upregulation of other acrolein-scavenging enzymes previously discussed, transient transfection assays were employed in this study, and 293T cells were chosen because of their high transfection efficiency and undetectable endogenous ARL-1 levels, which is critical in gene delivery studies. In addition, our observations focused on clonogenic growth of 293T cells, which is sensitive and reflects the growth properties of an individual cell, such as the viability and proliferation (Munshi et al., 2005; Pessina et al., 2005) . Further, the low acrolein concentrations used in this study allow for the evaluation of the data relevance to an objective situation in vivo.
Anchorage-dependent (plating efficiency in liquid culture) and anchorage-independent (in semisolid soft agar) growth of 293T cells were both tested. Anchorage-dependent colony formation assesses cell clonogenic ability on the surface of cell culture supports, while anchorage-independent growth tests the colony formation in semisolid medium, which is a hallmark of cellular transformation/tumorigenicity. In these observations, colony-formation rates, defined as the percentage of formed clones over the number of plated cells, were measured, and sizes of the surviving colonies were examined. The resulting data showed that 293T cells with EGFP/ARL-1 expression demonstrated higher colony formation rates in both liquid and semisolid culture and enhanced cell proliferation in soft agar, compared to the vector control cells, indicating that ARL-1 protected the clonogenic growth of 293T cells (Figs. 3 and 4) . Interestingly, this protective role of ARL-1 was observed in the 293T cells without additional acrolein stress, suggesting its regulation of endogenous acrolein stress produced during cell metabolism. However, a precaution needs to be taken in interpretation of the significance of this protection. In normal tissues such as in the gastrointestinal tract, expressed ARL-1 may benefit human health by detoxifying carbonyls produced during cell metabolism or originated from diets, whereas in HCC and lung cancer, the induced ARL-1 may facilitate cancer cell growth through the inactivation of antitumor drugs (Lee et al., 2001) .
At high concentrations of acrolein (25 and 50lM), EGFP/ ARL-1 prevented 293T cell death, as indicated by viable cell counting, LDH release into culture medium, and DNA fragmentation (Fig. 5 ). In cells with EGFP/ARL-1 protein expression, LDH efflux was nearly twofold lower than in the vector control cells. DNA fragment amounts were also remarkably decreased in EGFP/ARL-1 cells. Of the known forms of cell death, apoptosis is marked by cell shrinking, chromatin condensation and margination, and membrane ruffling, but membrane disintegration does not occur. Oppositely, necrosis is characterized by cell swelling and cellular lysis, resulting in the release of intracellular components. Similar to necrosis, oncosis is marked with cell swelling and membrane disintegration, but oncotic cells may also exhibit annexin V staining and/or DNA fragmentation (Van Cruchten and Van Den Broeck, 2002) . In this study, acrolein-induced cell death was accompanied by disintegration of cytoplasmic membranes and DNA fragmentations, indicating that 293T cells may experience an oncotic cell death. EGFP/ARL-1 protein prevented 293T cell death via this mechanism.
In summary, this study proved for the first time that ARL-1 protects 293T cells from acrolein lesions. Acrolein is a highly cytotoxic and genotoxic compound persistently formed during cell metabolism and naturally dispersed in living environments. This identification and verification of ARL-1 as a novel detoxification enzyme of acrolein is important to the issue of acrolein metabolism and toxicity.
